However, recent in vitro studies showed that NUCB2/NESF-1 knockdown with siRNA or shRNA in bladder cancer, glioblastoma, endometrial cancer, and thyroid cancer cell lines resulted in the inhibition of cell proliferation [19,22,25]. The gene discussed is NUCB2; the disease is thyroid cancer.